Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
JAMA. 2024 Apr 2;331(13):1135-1144. doi: 10.1001/jama.2024.3056.
JAMA. 2024.
PMID: 38563834
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Colomba E, Jonas SF, Eymard JC, Delva R, Brachet PE, Neuzillet Y, Penel N, Roubaud G, Bompas E, Mahammedi H, Longo R, Helissey C, Barthélemy P, Borchiellini D, Hasbini A, Priou F, Saldana C, Voog E, Narcisso B, Ladoire S, Berdah JF, Aisenfarb JB, Foulon S, Fizazi K.
Colomba E, et al. Among authors: jonas sf.
Eur Urol. 2024 Mar;85(3):274-282. doi: 10.1016/j.eururo.2023.05.009. Epub 2023 Jun 2.
Eur Urol. 2024.
PMID: 37271630
Clinical Trial.
Item in Clipboard
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
Park JH, Jonas SF, Bataillon G, Criscitiello C, Salgado R, Loi S, Viale G, Lee HJ, Dieci MV, Kim SB, Vincent-Salomon A, Curigliano G, André F, Michiels S.
Park JH, et al. Among authors: jonas sf.
Ann Oncol. 2019 Dec 1;30(12):1941-1949. doi: 10.1093/annonc/mdz395.
Ann Oncol. 2019.
PMID: 31566659
Free article.
Item in Clipboard
A test for comparing current status survival data with crossing hazard functions and its application to immunogenicity of biotherapeutics.
Jonas SF, Mbogning C, Broët P.
Jonas SF, et al.
Stat Med. 2017 Nov 30;36(27):4364-4377. doi: 10.1002/sim.7439. Epub 2017 Aug 30.
Stat Med. 2017.
PMID: 28856703
Item in Clipboard
A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.
Jonas SF, Mbogning C, Hässler S, Broët P.
Jonas SF, et al.
PLoS One. 2017 Jun 30;12(6):e0179896. doi: 10.1371/journal.pone.0179896. eCollection 2017.
PLoS One. 2017.
PMID: 28665947
Free PMC article.
Item in Clipboard
Age-at-onset subsets of bipolar I disorders: A critical insight into admixture analyses.
Montlahuc C, Curis E, Jonas SF, Bellivier F, Chevret S.
Montlahuc C, et al. Among authors: jonas sf.
Int J Methods Psychiatr Res. 2017 Sep;26(3):e1536. doi: 10.1002/mpr.1536. Epub 2016 Oct 21.
Int J Methods Psychiatr Res. 2017.
PMID: 27766706
Free PMC article.
Item in Clipboard
Cite
Cite